Piramal Pharma Solutions

Speed, precision, and personalization - these are the forces redefining drug development in 2025. From AI-driven discovery to next-gen modalities, drug development in 2025 is moving faster and smarter than ever. At Piramal Pharma Solutions, we partner with innovators to turn these advances into therapies that truly impact patients. Explore the trends shaping the future of pharma in our latest blog: https://lnkd.in/dXqzZ7ut #PiramalPharmaSolutions #Blog #Drugdevelopment #AI

Great ideas often begin with great conversations.   We’re excited to host our next Science on Tap evening on Dec 3rd in Cambridge, MA — a relaxed, networking evening with our Business Development leadership and senior management team. Join us for cocktails, conversation, and cross-industry connections as we continue the dialogue around innovation and drug development.   Date: Wednesday December 3rd, 2025 Time: 5:00 pm - 8:00 pm Venue: Sulmona Restaurant and Bar, 608 Main Street, Cambridge, MA. RSVP: stuart.needleman@piramal.com Abbie Meyer Mota Stuart Needleman Jason Dwinell Paul Defina #PiramalPharmaSolutions #BusinessDevelopment #Leadership #Cambridge

Join us on December 3rd in Cambridge, MA for our next Global Lunch & Learn Technical Seminar. This session will focus on: Overcoming the Technical Challenges in ADC Development.   Our ADC technical expert, Conor Barry—and a key member of the Piramal Pharma Solutions Science Collective—will lead an in-depth discussion on strategies, pitfalls, and innovations shaping today’s ADC programs.   Looking forward to engaging with the scientific community!   Date: Wednesday Dec 3rd, 2025 Time: 12:00 pm – 2:00 pm (lunch will be served) Venue: Catalyst Restaurant, 300 technology Square, Cambridge, MA. RSVP: stuart.needleman@piramal.com Abbie Meyer Mota Stuart Needleman Jason Dwinell Paul Defina #PiramalPharmaSolutions #ADC #Development #GlobalLunch #TechnicalSeminar #Innovation

Behind every breakthrough is a shared mission: to make a difference where it matters most. From our scientists shaping solutions to patients finding relief, every milestone reflects care in motion. Because at Piramal Pharma Solutions, patient centricity lies at the core of everything we do. #PiramalPharmaSolutions, #PatientCentricity

At Piramal Pharma Solutions, our focus on quality and innovation continues to guide how we support partners in advancing complex therapeutics. We are pleased to announce that our Grangemouth, UK facility has received updated MHRA GMP certificates, further strengthening its robust regulatory foundation and bioconjugation capabilities. The certificates cover all operations across the Helix building, including its warehouse and laboratory areas, following a successful compliance review and desktop inspection. With this update, the site remains fully equipped to support clinical and commercial drug substance development, manufacturing, and testing with precision and reliability. This achievement also reinforces Grangemouth’s critical role in ADCelerate™, our integrated pathway that accelerates the journey from R&D to GMP manufacturing. Through ADCelerate™, we help partners move to clinic faster with high-quality, end-to-end bioconjugate solutions. With these updated certifications, PPS continues to uphold the highest standards of quality and regulatory excellence, empowering our customers to advance therapies that can make a meaningful difference for patients worldwide. Read the full press release here: https://lnkd.in/d9dduT4z #PiramalPharmaSolutions #Grangemouth #ADCelerate #Bioconjugate

We’re gearing up for CPhI India 2025! Visit Piramal Pharma Solutions at Booth 4.H05 and connect with our API Generics leadership team to explore opportunities to collaborate across development, scale-up, and commercial API supply. Discover how our decades of chemistry expertise, global quality systems, and reliable manufacturing network enable us to deliver high-quality, cost-effective API solutions across key therapeutic categories. Stop by and let’s discuss how we can partner for your next breakthrough. Shreeram Kanetkar Harpreet Singh Tuteja #CPhIIndia #PiramalPharmaSolutions #APIGenerics #PharmaPartnerships #CDMO

From validated methods to regulatory readiness, analytical development keeps every batch consistent and compliant. It not only forms the backbone of safe, high-quality pharmaceuticals but also ensures that every batch meets the highest standards of quality, potency, and stability safeguarding patients and supporting regulatory success. Building on this foundation, Piramal Pharma Solutions’ analytical strength and CDMO expertise empower drug developers to accelerate timelines while maintaining complete compliance and trust. Interested in learning more? Head to our blog: https://lnkd.in/dv_64aR8 #PiramalPharmaSolutions #DrugManufacturing #Development #Blog

Let’s talk APIs that power progress. At Piramal Pharma Solutions, our API Generics business combines decades of chemistry expertise, global manufacturing strength, and a commitment to quality and compliance — delivering reliable, scalable, and cost-effective API solutions across key therapeutic areas. Meet our API Generics team, led by Shreeram Kanetkar, Business Head – API Generics, at CPhI India 2025, and explore how we can support your formulation needs with a robust pipeline, secure supply, and end-to-end technical support. Visit us at Booth No: 4.H05 Let’s discuss how we can partner to bring differentiated value to your API strategy. #CPhIIndia #PiramalPharma #APIGenerics #CDMO #PharmaPartnerships #APISolutions #GlobalQuality

Connect with our API Generics team at CPhI India 2025! Our API Generics business brings together deep chemistry expertise, global manufacturing capabilities, and a commitment to dependable supply — helping partners accelerate programs and bring impactful medicines to market. Meet Harpreet Singh Tuteja, DGM – Business Development, and discover how Piramal Pharma Solutions delivers reliability, quality, and scale across a wide portfolio of APIs. From process development to commercial-scale manufacturing, our API Generics business is built on scientific excellence, quality systems, and a robust global network. Booth No: 4.H05 Let’s connect and explore how we can partner for long-term success. #CPhIIndia #APIGenerics #PiramalPharma #TrustedPartner #PharmaSolutions

Developing biologics is a complex journey, requiring expertise, precision, and compliance at every step. From monoclonal antibodies to cell and gene therapies, biologics CDMOs help transform groundbreaking science into real-world treatments. By supporting cell line development, upstream and downstream processing, formulation, and regulatory adherence, CDMOs reduce timelines and costs while ensuring quality and patient safety. At Piramal Pharma Solutions, we collaborate with pharma and biotech innovators worldwide to simplify biologics development and accelerate access to life-saving therapies. Want to understand how CDMOs make large molecule drug development possible? Read our latest blog: https://lnkd.in/ds6-HiKs #PiramalPharmaSolutions #Blog #Development #CDMO #Biologics #Antibodies